John J Krais

Title: John J Krais: Innovator in Cancer Therapy

Introduction

John J Krais is a notable inventor based in Abington, PA (US). He has made significant contributions to the field of cancer therapy through his innovative work. His research focuses on developing methods to effectively target cancerous tumors, which can lead to improved treatment outcomes for patients.

Latest Patents

Krais holds a patent for an enzyme conjugate and prodrug cancer therapy. This patent describes a method and composition for treating a cancerous tumor by targeting the tumor's vasculature. The enzyme conjugate comprises a ligand that binds to endothelial cells in the tumor vasculature. This innovative approach converts a prodrug administered to the subject into an anticancer drug specifically within the tumor vasculature. Krais has 1 patent to his name.

Career Highlights

John J Krais is affiliated with the University of Oklahoma, where he continues to advance his research in cancer treatment. His work has the potential to change the landscape of cancer therapies, providing new hope for patients battling this disease.

Collaborations

Krais collaborates with Roger G Harrison, Jr., who is also involved in research related to cancer therapies. Their combined expertise enhances the potential for groundbreaking discoveries in this critical field.

Conclusion

John J Krais is a dedicated inventor whose work in enzyme conjugate and prodrug cancer therapy exemplifies innovation in medical research. His contributions are paving the way for more effective cancer treatments, ultimately benefiting patients in need.